The Effect of Complex Decongestıve Therapy on Oxıdatıve Stress and Antıoxıdants
Launched by BASKENT UNIVERSITY · Aug 23, 2024
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Lymphedema, which is the most common late complication of patients undergoing cancer treatment, affects the physical, social and psychological lives of the individual and decreases the quality of life as it causes motor dysfunctions, cosmetic deformations and psychological disorders. The addition of radiotherapy to surgical intervention increases the risk of lymphedema by 36%.
When free radicals increase in intensity, they cause structural defects in lipids, proteins and nucleic acids, and as a result, they are a cause and risk factor for chronic diseases such as cancer, neurodegenerative ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Development of lymphedema after breast cancer treatment
- • Clinical stage of lymphedema Stage-2 or Stage-3 diagnosis
- Exclusion Criteria:
- • Receiving treatment for lymphedema in the last three months
- • Those diagnosed with severe heart failure and/or arrhythmia
- • Persistent infection in the affected extremities
- • Ongoing chemotherapy treatment
- • Diagnosed with liver disease
About Baskent University
Baskent University is a distinguished academic and research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a strong emphasis on evidence-based medicine, the university collaborates with a network of healthcare professionals and researchers to design and implement rigorous clinical research that aims to improve patient outcomes. Baskent University is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its research initiatives while fostering a collaborative environment that promotes scientific discovery and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Adana, , Turkey
Adana, çukurova, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported